Reltecimod (AB-103) TFA 是一种 T 细胞特异性表面糖蛋白 CD28 (TP44) 拮抗剂。Reltecimod TFA 对不同的细菌感染、细菌外毒素和内毒素以及电离辐射都有良好的抗性作用。Reltecimod TFA 通过靶向和减弱关键的 CD28/B7-2 共刺激通路来调节炎症反应,而不抑制它。Reltecimod TFA 可用于研究坏死性软组织感染 (NSTIs)。
产品信息
| 产品名称 | Reltecimod TFA |
| 产品描述 | Reltecimod (AB-103) TFA is an antagonist of the T cell-specific surface glycoprotein CD28 (TP44). Reltecimod TFA has good resistance effects against different bacterial infections, bacterial exotoxins and endotoxins, and ionizing radiation. Reltecimod TFA modulates inflammatory responses by targeting and attenuating, but not inhibiting, the critical CD28/B7-2 costimulatory pathway. Reltecimod TFA can be used in research on necrotizing soft tissue infections (NSTIs). |
| 生物活性 | Reltecimod (AB-103) TFA is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod TFA has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod TFA modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod TFA can be used to research necrotizing soft-tissue infections (NSTIs). |
| 分子式 | C46H72N10O15S.xC2HF3O2 |
| 性状 | Solid |
| 颜色 | White to off-white |
| 序列 | {d-Ala}-Ser-Pro-Met-Leu-Val-Ala-Tyr-Asp-{d-Ala} |
| 序列缩写 | {d-Ala}-SPMLVAYD-{d-Ala} |
| 储存方式 | Sealed storage, away from moisture and light |


联系我们